Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Paula Candiota

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Metabolites|March 24, 2022
Establishing Imaging Biomarkers of Host Immune System Efficacy during Glioblastoma Therapy Response: Challenges, Obstacles and Future PerspectivesAna Paula Candiota, Carles Arús
NMR in Biomedicine|January 12, 2019
Cancer metabolism in a snapshot: MRS(I)Margarida Julià-Sapé, Ana Paula Candiota, Carles Arús
Magma (New York, N.Y.)|January 31, 2012
Minimization of spectral pattern changes during HRMAS experiments at 37 degrees celsius by prior focused microwave irradiationMyriam Davila, Ana Paula Candiota, Martí Pumarola, et al.
International Journal of Molecular Sciences|November 25, 2020
Anti-PD-1 Immunotherapy in Preclinical GL261 Glioblastoma: Influence of Therapeutic Parameters and Non-Invasive Response Biomarker Assessment with MRSI-Based ApproachesShuang Wu, Pilar Calero-Pérez, Carles Arús, et al.
Cancers|June 2, 2021
Immune System-Related Changes in Preclinical GL261 Glioblastoma under TMZ Treatment: Explaining MRSI-Based Nosological Imaging Findings with RT-PCR AnalysesPilar Calero-Pérez, Shuang Wu, Carles Arús, et al.
NMR in Biomedicine|September 11, 2014
Molecular imaging coupled to pattern recognition distinguishes response to temozolomide in preclinical glioblastomaTeresa Delgado-Goñi, Margarida Julià-Sapé, Ana Paula Candiota, et al.
Pathology Oncology Research : POR|October 16, 2015
Protein Kinase CK2 Content in GL261 Mouse GlioblastomaLaura Ferrer-Font, Estefania Alcaraz, Maria Plana, et al.
Nanomaterials (Basel, Switzerland)|May 27, 2023
Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?Paula Alfonso-Triguero, Julia Lorenzo, Ana Paula Candiota, et al.
Plos One|August 16, 2019
Embedding MRI information into MRSI data source extraction improves brain tumour delineation in animal modelsSandra Ortega-Martorell, Ana Paula Candiota, Ryan Thomson, et al.
Acta Biomaterialia|December 8, 2024
Synthesis and Relaxivity study of amino acid-branched radical dendrimers as MRI contrast agents for potential brain tumor imagingYufei Wu, Vega Lloveras, Silvia Lope-Piedrafita, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Metabolites|March 24, 2022
Establishing Imaging Biomarkers of Host Immune System Efficacy during Glioblastoma Therapy Response: Challenges, Obstacles and Future PerspectivesAna Paula Candiota, Carles Arús
NMR in Biomedicine|January 12, 2019
Cancer metabolism in a snapshot: MRS(I)Margarida Julià-Sapé, Ana Paula Candiota, Carles Arús
Magma (New York, N.Y.)|January 31, 2012
Minimization of spectral pattern changes during HRMAS experiments at 37 degrees celsius by prior focused microwave irradiationMyriam Davila, Ana Paula Candiota, Martí Pumarola, et al.
International Journal of Molecular Sciences|November 25, 2020
Anti-PD-1 Immunotherapy in Preclinical GL261 Glioblastoma: Influence of Therapeutic Parameters and Non-Invasive Response Biomarker Assessment with MRSI-Based ApproachesShuang Wu, Pilar Calero-Pérez, Carles Arús, et al.
Cancers|June 2, 2021
Immune System-Related Changes in Preclinical GL261 Glioblastoma under TMZ Treatment: Explaining MRSI-Based Nosological Imaging Findings with RT-PCR AnalysesPilar Calero-Pérez, Shuang Wu, Carles Arús, et al.
NMR in Biomedicine|September 11, 2014
Molecular imaging coupled to pattern recognition distinguishes response to temozolomide in preclinical glioblastomaTeresa Delgado-Goñi, Margarida Julià-Sapé, Ana Paula Candiota, et al.
Pathology Oncology Research : POR|October 16, 2015
Protein Kinase CK2 Content in GL261 Mouse GlioblastomaLaura Ferrer-Font, Estefania Alcaraz, Maria Plana, et al.
Nanomaterials (Basel, Switzerland)|May 27, 2023
Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?Paula Alfonso-Triguero, Julia Lorenzo, Ana Paula Candiota, et al.
Plos One|August 16, 2019
Embedding MRI information into MRSI data source extraction improves brain tumour delineation in animal modelsSandra Ortega-Martorell, Ana Paula Candiota, Ryan Thomson, et al.
Acta Biomaterialia|December 8, 2024
Synthesis and Relaxivity study of amino acid-branched radical dendrimers as MRI contrast agents for potential brain tumor imagingYufei Wu, Vega Lloveras, Silvia Lope-Piedrafita, et al.
Pageof 4